Fcgr2b and Fcgr3 are the major genetic factors for cartilage antibody‐induced arthritis, overriding the effect of Hc encoding complement C5
Zhongwei Xu,Àlex Moreno‐Giró,Danxia Zhao,Alexander Krämer,Rajan Kumar Pandey,Bingze Xu,Susanna L. Lundström,Rikard Holmdahl
DOI: https://doi.org/10.1002/eji.202350659
2024-02-07
European Journal of Immunology
Abstract:Illustration of cartilage antibody‐induced arthritis (CAIA). Arthritogenic antibodies bind and deposit onto the cartilage surface, thereby triggering the activation of FCGRs (mainly FCGR3), the release of cytokines and chemokines, and the infiltration of leukocytes. Like rheumatoid arthritis (RA) in humans, collagen‐induced arthritis (CIA) in mice is associated with not only MHC class II genetic polymorphism but also, to some extent, with other loci including genes encoding Fc gamma receptors (FCGRs) and complement C5. In this study, we used a cartilage antibody‐induced arthritis (CAIA) model in which arthritis develops within a 12‐h timeframe, to determine the relative importance of FCGRs and C5 (Hc). In CAIA, inhibiting or deleting FCGR3 substantially hindered arthritis development, underscoring the crucial role of this receptor. Blocking FCGR3 also reduced the levels of FCGR4, and vice versa. When employing an IgG1 arthritogenic cocktail that exclusively interacts with FCGR2B and FCGR3, joint inflammation was promptly initiated in Fcgr2b−− mice but not in Fcgr3−− mice, suggesting that FCGR3 is sufficient for CAIA development. Regarding complement activation, Fcgr2b++.Hc** mice with C5 mutated were fully resistant to CAIA, whereas Fcgr2b−−.Hc** mice developed arthritis rapidly. We conclude that FCGR3 is essential and sufficient for CAIA development, particularly when induced by IgG1 antibodies. The human ortholog of mouse FCGR3, FCGR2A, may be associated with RA pathogenesis. FCGR2B deficiency allows for rapid arthritis progression and overrides the resistance conferred by C5 deficiency.
immunology